Studying eye tissue to understand advanced diabetic retinopathy
Part of Eyes & vision, Heart & circulation, Hormones & metabolism clinical trials.
This study looks at eye tissue from people with advanced diabetic retinopathy to understand why the disease gets so severe. It aims to find new ways to treat or prevent blindness in the future. You would be contributing tissue from a surgery you're already having.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have severe, advanced diabetic retinopathy (a serious eye problem from diabetes) that has led to blindness or shrinking of the eye.
- You are willing to have surgery to remove the blind eye and get an artificial eye (enucleation and ocular prosthesis).
- Or, you have severe diabetic retinopathy and need a surgery called vitrectomy to try to preserve your vision.
- You are generally healthy without serious conditions like autoimmune diseases or cancer.
- You agree to participate and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for specific eye findings (“biomarkers”) in people with type 2 diabetes using eye imaging. It may help researchers better understand diabetic retinopathy and how to detect it earlier or more accurately.
This study tests a new approach aimed at improving diabetic eye disease (diabetic retinopathy). It may help by changing inflammation and related processes in the eye, especially in people who have diabetes and eye changes.
This study closely follows people with type 2 diabetes who have early signs of diabetic retinopathy (damage to the retina from diabetes) to see how the condition changes over time. It does not test a new treatment but monitors the eye's health closely. It may be a good fit if you have diabetic retinopathy that does not need immediate treatment.
This study looks back at medical records of people with type 2 diabetes to understand how diabetic eye disease (retinopathy) progresses and when treatment is needed. It may help doctors better predict risks and guide future care.
This study uses special eye photographs to look at early signs of diabetes damage in the eyes and kidneys. It may help doctors predict how diabetes complications progress and plan better care.
This study tests whether using a special eye scan (OCTA) to guide targeted laser treatment can slow down the progression of areas with poor blood flow in the retina of people with diabetic retinopathy. The goal is to prevent the condition from getting worse and help preserve your vision.
Hear when a new Diabetic Retinopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.